Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Shenling Baizhu Powder for Allergic Asthma
NCT07352488Not yet recruiting
- Sponsor
- Henan University of Chinese Medicine
- Start
- Jan 2026
- Primary completion
- Sep 2027
- Modality
- Herbal formula
- Countries
- 1
01
Overview
Randomised, double-blind trial of Modified Shenling Baizhu San in allergic asthma (2 arms), sponsored by Henan University of Chinese Medicine. Primary endpoint: Asthma Control Test at 20 weeks. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Modified Shenling Baizhu San
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT07352488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07352488.